Delivery Order SPE2DB25D3201-SPE2DB25FNVAN
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ruxience 500 mg/50 mL vials with a contract value of $2,935.32 and a completion date of August 5, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and represents a pharmaceutical supply transaction under the company's existing Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ruxience 500 mg/50 mL vials, a biosimilar medication used in cancer treatment. This firm fixed-price delivery order, valued at $7,421.74, represents a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The pharmaceutical products will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.70 firm fixed price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The IDC, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a potential value of $999,999,999.00 and is the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense....
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a ceiling value of $25,487.39 and a completion date of July 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,956.88, is a delivery order for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award, valued at $25,827.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug RUXIENCE 500 MG/50 ML VIAL 50ML. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,913.72 firm fixed-price contract is for the delivery of the medication RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of July 3, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RUXIENCE 100 MG/10 ML VIAL 10ML medical supplies. The contract, valued at $1,218.60, was awarded on June 25, 2024, with a completion date of June 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...